StockMacro
Menu

Perrigo

$15.94 +48% in 6 monthsMarket cap $2.2B

PRGO on XNYS, Health Care, PERRIGO COMPANY PLC, job postings

Measures activity, not value. Not investment advice.

Revenue fell 5.2% last quarter and the 12-month net loss is $1.8B, but shares rose 30% in a year.

  • BadShort interest at 18% of shares, 11.3 days to cover

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 26 Sep 2026

Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix centers on private-label consumer health goods sold to major retailers such as Walmart, Amazon.com, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Industry
Pharmaceutical preparations (Health Care)
Employees
8,100
Website
perrigo.com
Listed
NYSE, US
Last results
4 Nov 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 26 Sep 2026: revenue $988.6M, net loss $27.5M.
Quarter to 31 Dec 2021: revenue –, net income $9.6MQuarter to 2 Apr 2022: revenue $1.1B, net income -$2.4MQuarter to 2 Apr 2022: revenue $1.1B, net income -$2.4MQuarter to 2 Jul 2022: revenue $1.1B, net income -$65.1MQuarter to 2 Jul 2022: revenue $1.1B, net income -$65.1MQuarter to 1 Oct 2022: revenue $1.1B, net income -$49.4MQuarter to 1 Oct 2022: revenue $1.1B, net income -$49.4MQuarter to 31 Dec 2022: revenue –, net income -$23.7MQuarter to 1 Apr 2023: revenue $1.2B, net income -$3.0MQuarter to 1 Apr 2023: revenue $1.2B, net income -$3.0MQuarter to 1 Jul 2023: revenue $1.2B, net income $8.4MQuarter to 1 Jul 2023: revenue $1.2B, net income $8.4MQuarter to 30 Sep 2023: revenue $1.1B, net income $14.2MQuarter to 30 Sep 2023: revenue $1.1B, net income $14.2MQuarter to 31 Dec 2023: revenue $1.2B, net income -$32.3MQuarter to 31 Dec 2023: revenue $1.2B, net income -$32.3MQuarter to 30 Mar 2024: revenue $1.1B, net income $2.0MQuarter to 30 Mar 2024: revenue $1.1B, net income $2.0MQuarter to 29 Jun 2024: revenue $1.1B, net income -$108.4MQuarter to 29 Jun 2024: revenue $1.1B, net income -$108.4MQuarter to 28 Sep 2024: revenue $1.1B, net income -$21.0MQuarter to 28 Sep 2024: revenue $1.1B, net income -$21.0MQuarter to 31 Dec 2024: revenue $1.1B, net income -$44.5MQuarter to 31 Dec 2024: revenue $1.1B, net income -$44.5MQuarter to 29 Mar 2025: revenue $1.0B, net income -$6.4MQuarter to 29 Mar 2025: revenue $1.0B, net income -$6.4MQuarter to 28 Jun 2025: revenue $1.1B, net income -$8.4MQuarter to 28 Jun 2025: revenue $1.1B, net income -$8.4MQuarter to 27 Sep 2025: revenue $1.0B, net income $7.5MQuarter to 27 Sep 2025: revenue $1.0B, net income $7.5MQuarter to 31 Dec 2025: revenue $1.1B, net income -$1.4BQuarter to 31 Dec 2025: revenue $1.1B, net income -$1.4BQuarter to 28 Mar 2026: revenue $969.2M, net income -$398.6MQuarter to 28 Mar 2026: revenue $969.2M, net income -$398.6MQuarter to 27 Jun 2026: revenue $1.0B, net income $74.5MQuarter to 27 Jun 2026: revenue $1.0B, net income $74.5MQuarter to 26 Sep 2026: revenue $988.6M, net income -$27.5MQuarter to 26 Sep 2026: revenue $988.6M, net income -$27.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $1.4B26 Sep 2026
See the numbers
Quarter toRevenueNet income
26 Sep 2026$988.6M-$27.5M
27 Jun 2026$1.0B$74.5M
28 Mar 2026$969.2M-$398.6M
31 Dec 2025$1.1B-$1.4B
27 Sep 2025$1.0B$7.5M
28 Jun 2025$1.1B-$8.4M
29 Mar 2025$1.0B-$6.4M
31 Dec 2024$1.1B-$44.5M
28 Sep 2024$1.1B-$21.0M
29 Jun 2024$1.1B-$108.4M
30 Mar 2024$1.1B$2.0M
31 Dec 2023$1.2B-$32.3M
30 Sep 2023$1.1B$14.2M
1 Jul 2023$1.2B$8.4M
1 Apr 2023$1.2B-$3.0M
31 Dec 2022–-$23.7M
1 Oct 2022$1.1B-$49.4M
2 Jul 2022$1.1B-$65.1M
2 Apr 2022$1.1B-$2.4M
31 Dec 2021–$9.6M
Fundamentals, 12 months to 26 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $4.1B $4.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -4.5% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$1.8B -$51.8M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$12.78 -$0.38
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 32.3% 35.5% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -39.4% 6.5% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -43.3% -1.2% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -51.4% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $168.2M $271.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $436.6M $432.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $3.3B $3.6B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $2.9B $3.2B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.3 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $17.58
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.54 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.2 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.91 2.0
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 7.3% 2.5%

Latest = 12 months to 26 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
PerrigoPRGO (this company) $2.2Bloss0.54-4.5%-43.3%
NewAmsterdam PharmaNAMS $2.2Bloss85.1-26%-790%
Arcus BiosciencesRCUS $2.2Bloss22.5-58%-453%
Palvella TherapeuticsPVLA $2.1Bloss–––
Prestige Consumer HealthcarePBH $2.4B15.22.0+5.1%13.3%
MBX BiosciencesMBX $2.5Bloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.2%

334 13F filers vs 330

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

152.7M shares held by 13F filers (30 Sep 2026) of 138.8M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

18%

24.6M shares sold short (30 Oct 2026) of 138.8M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

11.3

24.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+1.8%

24.2M shares sold short in the report before, 24.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 60%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

92

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-5.2%

$988.6M vs $1.0B (quarter ended 26 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-20%

$17.5M vs $21.9M (quarter ended 26 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$110K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

12

12 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.0×

12 articles in the last 7 days; its usual week has 2.

Price $15.94 on 20 Nov 2026, +30% over 12 months (12-month range $9.25 to $16.95)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: -$155K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 4 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $988.6M in the latest quarter, -5.2% on a year earlier.
Capital spending per quarter. Capital spending $17.5M in the latest quarter, -20% on a year earlier.
Institutional holders (13F filers). 334 13F filers reported holding it in the latest 13F quarter, +7.7% on a year earlier.
Lobbying spend. Lobbying spend: $110K published in the last 12 months, -62% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
6 Jul 20268-K and other filingsDirector or officer change
30 Jun 20268-K and other filingsDirector or officer change
8 Jun 20268-K and other filingsDirector or officer change
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 59 vs usual 38.50 (2026-03-31); 1.6x the same period a year earlier
5 May 20268-K and other filingsDirector or officer change
5 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Apr 20268-K and other filingsCompleted an acquisition or asset sale
16 Apr 2026Lobbying filingnew lobbying registration (COVINGTON & BURLING LLP)
17 Feb 2026Sharp changeShort interest spike: short interest spike, 15.8M vs usual 6.0M (2026-01-30); 3.0x the same period a year earlier
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 65 vs usual 38.50 (2025-12-31); 1.6x the same period a year earlier
3 Feb 2026Sharp changeShort interest spike: short interest spike, 13.9M vs usual 5.6M (2026-01-15); 2.5x the same period a year earlier
13 Jan 2026Sharp changeShort interest spike: short interest spike, 15.4M vs usual 5.4M (2025-12-31); 3.4x the same period a year earlier
30 Dec 2025Sharp changeShort interest spike: short interest spike, 13.9M vs usual 5.3M (2025-12-15); 3.0x the same period a year earlier
16 Dec 2025Sharp changeShort interest spike: short interest spike, 14.2M vs usual 5.3M (2025-11-28); 3.5x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 11.9M vs usual 5.2M (2025-11-14); 2.4x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 10.1M vs usual 5.1M (2025-10-31); 2.0x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 11.5M vs usual 5.1M (2025-10-15); 2.1x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 8.7M vs usual 5.1M (2025-09-30); 1.7x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 7.4M vs usual 5.0M (2025-08-29); 1.4x the same period a year earlier
20 Aug 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 268K)
18 Jul 2025Sharp changeLobbying on a new issue: lobbying on a new issue: AGR, BUD (2025-06-30)
17 Jul 2025Lobbying filingnew lobbying registration (SQUIRE PATTON BOGGS)
1 Jul 20258-K and other filingsDirector or officer change
4 Jun 20258-K and other filingsDirector or officer change
4 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Feb 20258-K and other filingsDirector or officer change
3 Feb 20258-K and other filingsDirector or officer change
16 Jan 20258-K and other filingsDirector or officer change
16 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 20248-K and other filingsDirector or officer change
10 Jun 20248-K and other filingsDirector or officer change
28 May 20248-K and other filingsDirector or officer change
7 May 20248-K and other filingsDirector or officer change
23 Apr 2024Sharp changeLobbying spend jump: lobbying spend jump, 380K vs usual 100K (2024-03-31); 12.7x the same period a year earlier
8 Mar 2024Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 4 filing(s) in 30 days, value_usd total 526K)
6 Mar 20248-K and other filingsDirector or officer change
6 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Nov 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 525K)
11 Sep 20238-K and other filingsDirector or officer change
9 Aug 20238-K and other filingsDirector or officer change
8 Jun 20238-K and other filingsDirector or officer change
9 May 20238-K and other filingsDirector or officer change
9 Feb 20238-K and other filingsDirector or officer change
9 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Oct 2022Sharp changeLobbying on a new issue: lobbying on a new issue: MAN (2022-09-30)
12 Aug 2022Lobbying filingnew lobbying registration (ARNOLD & PORTER KAYE SCHOLER LLP)
14 Jul 20228-K and other filingsDirector or officer change
11 May 20228-K and other filingsDirector or officer change
2 May 20228-K and other filingsCompleted an acquisition or asset sale
20 Apr 20228-K and other filingsA major agreement ended
24 Mar 20228-K and other filingsDirector or officer change
24 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Dec 2021Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 1.2M)
Insider net buying (open market)
Month from 1 Dec 2021: $2.0M published
Month from 1 Mar 2022: -$1.1M published
Month from 1 Dec 2022: -$75K published
Month from 1 Mar 2023: -$430K published
Month from 1 May 2023: -$7.0M published
Month from 1 Jun 2023: $331K published
Month from 1 Nov 2023: $697K published
Month from 1 Mar 2024: $526K published
Month from 1 Jun 2024: $28K published
Month from 1 Aug 2024: -$1.4M published
Month from 1 Sep 2024: -$244K published
Month from 1 Dec 2024: -$497K published
Month from 1 Mar 2025: -$214K published
Month from 1 May 2025: $95K published
Month from 1 Aug 2025: $304K published
Month from 1 Sep 2025: $51K published
Month from 1 Nov 2025: $106K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Jul 2026: 3 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 2 Apr 2022: $1.1B, +6.4% on a year earlier; public on 12 May 2022
Quarter ended 2 Jul 2022: $1.1B, +14% on a year earlier; public on 10 Aug 2022
Quarter ended 1 Oct 2022: $1.1B, +5.5% on a year earlier; public on 9 Nov 2022
Quarter ended 1 Apr 2023: $1.2B, +10% on a year earlier; public on 10 May 2023
Quarter ended 1 Jul 2023: $1.2B, +6.4% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.1B, +2.1% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $1.2B; public on 28 Feb 2024
Quarter ended 30 Mar 2024: $1.1B, -8.4% on a year earlier; public on 8 May 2024
Quarter ended 29 Jun 2024: $1.1B, -11% on a year earlier; public on 3 Aug 2024
Quarter ended 28 Sep 2024: $1.1B, -3.2% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $1.1B, -1.6% on a year earlier; public on 1 Mar 2025
Quarter ended 29 Mar 2025: $1.0B, -3.5% on a year earlier; public on 8 May 2025
Quarter ended 28 Jun 2025: $1.1B, -0.9% on a year earlier; public on 7 Aug 2025
Quarter ended 27 Sep 2025: $1.0B, -4.1% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $1.1B, -2.5% on a year earlier; public on 27 Feb 2026
Quarter ended 28 Mar 2026: $969.2M, -7.2% on a year earlier; public on 7 May 2026
Quarter ended 27 Jun 2026: $1.0B, -3.2% on a year earlier; public on 6 Aug 2026
Quarter ended 26 Sep 2026: $988.6M, -5.2% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $41.7M, -37% on a year earlier; public on 2 Mar 2022
Quarter ended 2 Apr 2022: $20.3M, -55% on a year earlier; public on 12 May 2022
Quarter ended 2 Jul 2022: $28.4M, +23% on a year earlier; public on 10 Aug 2022
Quarter ended 1 Oct 2022: $21.3M, -49% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $26.4M, -37% on a year earlier; public on 1 Mar 2023
Quarter ended 1 Apr 2023: $23.2M, +14% on a year earlier; public on 10 May 2023
Quarter ended 1 Jul 2023: $20.0M, -30% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $31.8M, +49% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $26.7M, +1.1% on a year earlier; public on 28 Feb 2024
Quarter ended 30 Mar 2024: $25.1M, +8.2% on a year earlier; public on 8 May 2024
Quarter ended 29 Jun 2024: $28.4M, +42% on a year earlier; public on 3 Aug 2024
Quarter ended 28 Sep 2024: $27.1M, -15% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $37.7M, +41% on a year earlier; public on 1 Mar 2025
Quarter ended 29 Mar 2025: $25.5M, +1.6% on a year earlier; public on 8 May 2025
Quarter ended 28 Jun 2025: $19.2M, -32% on a year earlier; public on 7 Aug 2025
Quarter ended 27 Sep 2025: $21.9M, -19% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $26.8M, -29% on a year earlier; public on 27 Feb 2026
Quarter ended 28 Mar 2026: $13.8M, -46% on a year earlier; public on 7 May 2026
Quarter ended 27 Jun 2026: $14.3M, -26% on a year earlier; public on 6 Aug 2026
Quarter ended 26 Sep 2026: $17.5M, -20% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 297; public on 14 Feb 2022
31 Mar 2022 report: 306; public on 16 May 2022
30 Jun 2022 report: 310; public on 15 Aug 2022
30 Sep 2022 report: 298; public on 14 Nov 2022
31 Dec 2022 report: 317; public on 14 Feb 2023
31 Mar 2023 report: 321; public on 15 May 2023
30 Jun 2023 report: 321; public on 14 Aug 2023
30 Sep 2023 report: 345; public on 14 Nov 2023
31 Dec 2023 report: 367; public on 14 Feb 2024
31 Mar 2024 report: 343; public on 15 May 2024
30 Jun 2024 report: 340; public on 14 Aug 2024
30 Sep 2024 report: 328; public on 14 Nov 2024
31 Dec 2024 report: 345; public on 14 Feb 2025
31 Mar 2025 report: 331; public on 15 May 2025
30 Jun 2025 report: 322; public on 14 Aug 2025
30 Sep 2025 report: 310; public on 14 Nov 2025
31 Dec 2025 report: 312; public on 17 Feb 2026
31 Mar 2026 report: 320; public on 15 May 2026
30 Jun 2026 report: 330; public on 14 Aug 2026
30 Sep 2026 report: 334; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Oct 2022: $100K published
Quarter from 1 Jan 2023: $100K published
Quarter from 1 Apr 2023: $30K published
Quarter from 1 Jul 2023: $120K published
Quarter from 1 Oct 2023: $90K published
Quarter from 1 Jan 2024: $170K published
Quarter from 1 Apr 2024: $380K published
Quarter from 1 Jul 2024: $70K published
Quarter from 1 Jan 2025: $60K published
Quarter from 1 Apr 2025: $170K published
Quarter from 1 Jul 2025: $60K published
Quarter from 1 Apr 2026: $90K published
Quarter from 1 Jul 2026: $20K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $106K (14 Nov 2025), 4.2× its normal reading; higher than 67% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: -$155K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 4 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $988.6M in the latest quarter, -5.2% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 88 insider trades

No trades in the last 90 days; the latest was filed 14 Nov 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
14 Nov 2025Geoffrey M. ParkerDirectorBuy7,500$14.18$106KForm 4
10 Sep 2025Abigail LennoxEVP and CSOBuy1,255$22.41$28KForm 4
9 Sep 2025Charles AtkinsonEVP, General Counsel & Sec.Buy1,000$23.20$23KForm 4
22 Aug 2025Robert WillisEVP & CHROBuy1,488$24.10$36KForm 4
19 Aug 2025Eduardo Guarita BezerraEVP & Chief Financial OfficerBuy3,000$22.74$68KForm 4
19 Aug 2025Geoffrey M. ParkerDirectorBuy4,375$22.97$100KForm 4
8 Aug 2025Patrick Lockwood-TaylorCEOBuy4,460$22.37$100KForm 4
14 May 2025Geoffrey M. ParkerDirectorBuy3,500$27.10$95KForm 4

334 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 54 opened a position, 54 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.23.4M16.9%$345.2M+685K+3.0%
Neuberger Berman Group LLC10.3M7.44%$152.5M-349K-3.3%
Vanguard Portfolio Management LLC9.1M6.54%$133.9M+26K+0.3%
State Street Corp8.6M6.22%$127.5M+109K+1.3%
Vanguard Capital Management LLC6.3M4.52%$92.5M+24K+0.4%
FMR LLC (Fidelity)6.2M4.50%$92.2M+5.9M16 times as many
Fuller & Thaler Asset Management, Inc.5.4M3.91%$80.2M-2.1M-28%
Invesco Ltd.5.0M3.62%$74.2M-840K-14%
Wellington Management Group LLP4.9M3.51%$71.9MNew+4.9M
Dimensional Fund Advisors LP4.6M3.32%$68.1M-854K-16%

Federal contracts

All 1 federal contracts

No new award in 12 months; the latest was signed 16 Feb 2010. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
16 Feb 2010Agency for International DevelopmentONGOING EMERGENCY EARTHQUAKE RESPONSE HUMANITARIAN SUPPORT REQUIREMENTS IN HAITI REQUIRED THE PURCHASE OF 3.3 MILLION ALUMINUM CANS OF MILK-BASED READY TO FEED INFANT FORMULA WITH DHA AND 5,000 PUNCH CAN OPENERS.USAspending

Company events

All 81 company events

In 12 months: 4 director or officer changes, 1 major agreement, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
6 Jul 2026Director or officer change8-K
30 Jun 2026Director or officer change8-K
8 Jun 2026Director or officer change8-K
5 May 2026Director or officer changeSame filing: shareholder vote results8-K
30 Apr 2026Completed an acquisition or asset sale8-K
23 Mar 2026Signed a major agreementSame filing: took on new debt8-K
14 Jul 2025Signed a major agreement8-K
1 Jul 2025Director or officer change8-K

92 open postings; careers site tracked since 21 Nov 2026. Most in Operations & administration 21%, Test, quality & reliability 13%, Manufacturing & production 12%, Marketing & communications 11%.

PostedJobLocation
21 Nov 2026or earlierProcess EngineerProcess engineering (semiconductor / materials)Bronx, NY, US, 10457
21 Nov 2026or earlierManufacturing Operator - 1st Shift Oral CareManufacturing & productionGrand Rapids, MI, US, 49512
21 Nov 2026or earlier3rd Shift Set Up TechnicianOperations & administrationBronx, NY, US, 10457
21 Nov 2026or earlierAdministrative AssistantExecutive & administrative supportCovington, OH, US, 45318
21 Nov 2026or earlierEHS ManagerFacilities & constructionCovington, OH, US, 45318
21 Nov 2026or earlier3rd Shift Line OperatorOperations & administrationBronx, NY, US, 10457
21 Nov 2026or earlierSenior Manager, Regulatory Affairs NA ClusterLegal, policy & complianceAllegan, MI, US, 49010
21 Nov 2026or earlier3rd Shift Facilities MechanicFacilities & constructionBronx, NY, US, 10457

Reported lobbying spend: $20K in Q2 2026, $90K in Q1 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
18 Mar 2026NewCovington & Burling LLPfor Perrigo Company PLCFederal policy matters related to the manufacturing of infant formula.Health issues, FOOFiling
16 Apr 2025NewSquire Patton Boggsfor Perrigo CompanyPublic policy support regarding FDA oversight of infant formula.Agriculture, Budget, FOOFiling
12 Jul 2022NewArnold & Porter Kaye Scholer LLPfor Perrigo Company PLCFederal policy matters related to various healthcare issues, including the manufacturing of infant formula.Health issues, ManufacturingFiling
31 Dec 2020EndedFti Government Affairsfor Perrigo, Inc.Not statedFiling
30 Jun 2019EndedForbes-Tatefor Laboratoire Hra PharmaNot statedFiling
31 Dec 2017EndedMr. Galen Reserfor Perrigo Inc (Through Fti Government Affairs)Monitor tax reform.; Dextromethorphan, Pseudoephedrine restriction issues.; Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSAs and HSAs to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures InitiTaxation, Health issues, PharmacyFiling
30 Jun 2017NewForbes-Tatefor Laboratoire Hra PharmaIssues related to reproductive health.Health issuesFiling
15 Mar 2013NewFti Government Affairsfor Perrigo, Inc.OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan,Pharmacy, Health issues, TaxationFiling

The 5 newest of 234 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

16 Sep 2025confirmed

Confirmed across sources Insiders and Institutional holdings and Short interest and volume

Perrigo (PRGO): had 3 insiders buy $268K of its shares on the open market within 30 days (3 filings); it also had 14.2M shares sold short in the 28 Nov 2025 report, 3.5× the same report last year; and it saw 65 13F filers open a new position in the quarter ended 31 Dec 2025, 1.6× the same quarter last year. Three unrelated kinds of activity within 181 days.

  • Insiders: Clustered insider buying, became public on 20 Aug 2025
  • Short interest and volume: Short interest spike, became public on 11 Sep 2025
  • Short interest and volume: Short interest spike, became public on 10 Oct 2025
  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
  • Short interest and volume: Short interest spike, became public on 13 Nov 2025
  • Short interest and volume: Short interest spike, became public on 26 Nov 2025
  • Short interest and volume: Short interest spike, became public on 10 Dec 2025
  • Short interest and volume: Short interest spike, became public on 25 Dec 2025
  • Short interest and volume: Short interest spike, became public on 13 Jan 2026
  • Short interest and volume: Short interest spike, became public on 28 Jan 2026
  • Institutional holdings: Many funds opening a new position, became public on 17 Feb 2026
  • Short interest and volume: Short interest spike, became public on 11 Feb 2026
2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M
The 28 Nov 2025 report against the 24 reports before it. this reportearliernormal: 5.3M
See the evidence (12 changes)

Insiders: Clustered insider buying became public on 20 Aug 2025

Perrigo had 3 insiders buy $268K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$268K
Window
21 Jul 2025 to 20 Aug 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 11 Sep 2025

Perrigo had 7.4M shares sold short in the 29 Aug 2025 report, 1.4× the same report last year.

This period
7.4M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
377K
How far from its usual level
+4.3
Same report last year
5.2M
History used
2,800 days
2024-08-30: 5.2M2024-09-13: 4.3M2024-09-30: 5.1M2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M
the 29 Aug 2025 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Oct 2025

Perrigo had 8.7M shares sold short in the 30 Sep 2025 report, 1.7× the same report last year.

This period
8.7M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
417K
How far from its usual level
+5.9
Same report last year
5.1M
History used
2,832 days
2024-09-30: 5.1M2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M
the 30 Sep 2025 report24 earlier reportsnormal: 5.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Oct 2025

Perrigo had 11.5M shares sold short in the 15 Oct 2025 report, 2.1× the same report last year.

This period
11.5M (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
449K
How far from its usual level
+9.6
Same report last year
5.5M
History used
2,847 days
2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M
the 15 Oct 2025 report24 earlier reportsnormal: 5.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Nov 2025

Perrigo had 10.1M shares sold short in the 31 Oct 2025 report, 2.0× the same report last year.

This period
10.1M (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
521K
How far from its usual level
+6.5
Same report last year
5.0M
History used
2,863 days
2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M
the 31 Oct 2025 report24 earlier reportsnormal: 5.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Nov 2025

Perrigo had 11.9M shares sold short in the 14 Nov 2025 report, 2.4× the same report last year.

This period
11.9M (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
626K
How far from its usual level
+7.1
Same report last year
5.0M
History used
2,877 days
2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M
the 14 Nov 2025 report24 earlier reportsnormal: 5.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Dec 2025

Perrigo had 14.2M shares sold short in the 28 Nov 2025 report, 3.5× the same report last year.

This period
14.2M (the 28 Nov 2025 report)
Normal report (median of 24 earlier)
5.3M
Typical spread (median absolute deviation)
727K
How far from its usual level
+8.3
Same report last year
4.0M
History used
2,891 days
2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M
the 28 Nov 2025 report24 earlier reportsnormal: 5.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Dec 2025

Perrigo had 13.9M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

This period
13.9M (the 15 Dec 2025 report)
Normal report (median of 24 earlier)
5.3M
Typical spread (median absolute deviation)
802K
How far from its usual level
+7.2
Same report last year
4.7M
History used
2,908 days
2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M
the 15 Dec 2025 report24 earlier reportsnormal: 5.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Jan 2026

Perrigo had 15.4M shares sold short in the 31 Dec 2025 report, 3.4× the same report last year.

This period
15.4M (the 31 Dec 2025 report)
Normal report (median of 24 earlier)
5.4M
Typical spread (median absolute deviation)
920K
How far from its usual level
+7.3
Same report last year
4.5M
History used
2,924 days
2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M
the 31 Dec 2025 report24 earlier reportsnormal: 5.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Jan 2026

Perrigo had 13.9M shares sold short in the 15 Jan 2026 report, 2.5× the same report last year.

This period
13.9M (the 15 Jan 2026 report)
Normal report (median of 24 earlier)
5.6M
Typical spread (median absolute deviation)
988K
How far from its usual level
+5.7
Same report last year
5.5M
History used
2,939 days
2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M2026-01-15: 13.9M
the 15 Jan 2026 report24 earlier reportsnormal: 5.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

Perrigo saw 65 13F filers open a new position in the quarter ended 31 Dec 2025, 1.6× the same quarter last year.

This period
65 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
38.5
Typical spread (median absolute deviation)
3
How far from its usual level
+6.0
Same quarter last year
40
History used
4,475 days
2023-12-31: 482024-03-31: 382024-06-30: 462024-09-30: 352024-12-31: 402025-03-31: 362025-06-30: 312025-09-30: 392025-12-31: 65
the quarter ended 31 Dec 20258 earlier quartersnormal: 38.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 11 Feb 2026

Perrigo had 15.8M shares sold short in the 30 Jan 2026 report, 3.0× the same report last year.

This period
15.8M (the 30 Jan 2026 report)
Normal report (median of 24 earlier)
6.0M
Typical spread (median absolute deviation)
1.4M
How far from its usual level
+4.8
Same report last year
5.3M
History used
2,954 days
2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M2026-01-15: 13.9M2026-01-30: 15.8M
the 30 Jan 2026 report24 earlier reportsnormal: 6.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 6 Jul 2026Filings record

    Director or officer change

  2. 30 Jun 2026Filings record

    Director or officer change

  3. 8 Jun 2026Filings record

    Director or officer change

  4. 15 May 2026Institutional holdings change

    saw 59 13F filers open a new position in the quarter ended 31 Mar 2026, 1.6× the same quarter last year.

    Same quarter last year: 36; its normal quarter is 38.5.

    See the evidence
    This period
    59 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    38.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +4.6
    Same quarter last year
    36
    History used
    4,565 days
    2024-03-31: 382024-06-30: 462024-09-30: 352024-12-31: 402025-03-31: 362025-06-30: 312025-09-30: 392025-12-31: 652026-03-31: 59
    the quarter ended 31 Mar 20268 earlier quartersnormal: 38.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 5 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 5 May 2026Filings record

    Director or officer change

  7. 30 Apr 2026Filings record

    Completed an acquisition or asset sale

  8. 16 Apr 2026Lobbying record

    PERRIGO COMPANY PLC: new lobbying registration (COVINGTON & BURLING LLP) (dated 18 Mar 2026)

  9. 17 Feb 2026Institutional holdings change

    saw 65 13F filers open a new position in the quarter ended 31 Dec 2025, 1.6× the same quarter last year.

    Same quarter last year: 40; its normal quarter is 38.5.

    See the evidence
    This period
    65 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    38.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.0
    Same quarter last year
    40
    History used
    4,475 days
    2023-12-31: 482024-03-31: 382024-06-30: 462024-09-30: 352024-12-31: 402025-03-31: 362025-06-30: 312025-09-30: 392025-12-31: 65
    the quarter ended 31 Dec 20258 earlier quartersnormal: 38.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  10. 11 Feb 2026Short interest and volume change

    had 15.8M shares sold short in the 30 Jan 2026 report, 3.0× the same report last year.

    Same report last year: 5.3M; its normal report is 6.0M.

    See the evidence
    This period
    15.8M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    6.0M
    Typical spread (median absolute deviation)
    1.4M
    How far from its usual level
    +4.8
    Same report last year
    5.3M
    History used
    2,954 days
    2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M2026-01-15: 13.9M2026-01-30: 15.8M
    the 30 Jan 2026 report24 earlier reportsnormal: 6.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 28 Jan 2026Short interest and volume change

    had 13.9M shares sold short in the 15 Jan 2026 report, 2.5× the same report last year.

    Same report last year: 5.5M; its normal report is 5.6M.

    See the evidence
    This period
    13.9M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    5.6M
    Typical spread (median absolute deviation)
    988K
    How far from its usual level
    +5.7
    Same report last year
    5.5M
    History used
    2,939 days
    2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M2026-01-15: 13.9M
    the 15 Jan 2026 report24 earlier reportsnormal: 5.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 13 Jan 2026Short interest and volume change

    had 15.4M shares sold short in the 31 Dec 2025 report, 3.4× the same report last year.

    Same report last year: 4.5M; its normal report is 5.4M.

    See the evidence
    This period
    15.4M (the 31 Dec 2025 report)
    Normal report (median of 24 earlier)
    5.4M
    Typical spread (median absolute deviation)
    920K
    How far from its usual level
    +7.3
    Same report last year
    4.5M
    History used
    2,924 days
    2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M
    the 31 Dec 2025 report24 earlier reportsnormal: 5.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 25 Dec 2025Short interest and volume change

    had 13.9M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

    Same report last year: 4.7M; its normal report is 5.3M.

    See the evidence
    This period
    13.9M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    802K
    How far from its usual level
    +7.2
    Same report last year
    4.7M
    History used
    2,908 days
    2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M
    the 15 Dec 2025 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 10 Dec 2025Short interest and volume change

    had 14.2M shares sold short in the 28 Nov 2025 report, 3.5× the same report last year.

    Same report last year: 4.0M; its normal report is 5.3M.

    See the evidence
    This period
    14.2M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    727K
    How far from its usual level
    +8.3
    Same report last year
    4.0M
    History used
    2,891 days
    2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M
    the 28 Nov 2025 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 26 Nov 2025Short interest and volume change

    had 11.9M shares sold short in the 14 Nov 2025 report, 2.4× the same report last year.

    Same report last year: 5.0M; its normal report is 5.2M.

    See the evidence
    This period
    11.9M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    626K
    How far from its usual level
    +7.1
    Same report last year
    5.0M
    History used
    2,877 days
    2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M
    the 14 Nov 2025 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 15 Nov 2025Insiders record

    Parker Geoffrey M. (director) bought 7,500 shares of PRGO ($106,350) (dated 14 Nov 2025)

  17. 13 Nov 2025Short interest and volume change

    had 10.1M shares sold short in the 31 Oct 2025 report, 2.0× the same report last year.

    Same report last year: 5.0M; its normal report is 5.1M.

    See the evidence
    This period
    10.1M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    521K
    How far from its usual level
    +6.5
    Same report last year
    5.0M
    History used
    2,863 days
    2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M
    the 31 Oct 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 25 Oct 2025Short interest and volume change

    had 11.5M shares sold short in the 15 Oct 2025 report, 2.1× the same report last year.

    Same report last year: 5.5M; its normal report is 5.1M.

    See the evidence
    This period
    11.5M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    449K
    How far from its usual level
    +9.6
    Same report last year
    5.5M
    History used
    2,847 days
    2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M
    the 15 Oct 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 10 Oct 2025Short interest and volume change

    had 8.7M shares sold short in the 30 Sep 2025 report, 1.7× the same report last year.

    Same report last year: 5.1M; its normal report is 5.1M.

    See the evidence
    This period
    8.7M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    417K
    How far from its usual level
    +5.9
    Same report last year
    5.1M
    History used
    2,832 days
    2024-09-30: 5.1M2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M
    the 30 Sep 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 16 Sep 2025several at once

    had 3 insiders buy $268K of its shares on the open market within 30 days (3 filings); it also had 14.2M shares sold short in the 28 Nov 2025 report, 3.5× the same report last year; and it saw 65 13F filers open a new position in the quarter ended 31 Dec 2025, 1.6× the same quarter last year. Three unrelated kinds of activity within 181 days.

    See the evidence (12 changes)

    Insiders: Clustered insider buying became public on 20 Aug 2025

    Perrigo had 3 insiders buy $268K of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $268K
    Window
    21 Jul 2025 to 20 Aug 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 11 Sep 2025

    Perrigo had 7.4M shares sold short in the 29 Aug 2025 report, 1.4× the same report last year.

    This period
    7.4M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    377K
    How far from its usual level
    +4.3
    Same report last year
    5.2M
    History used
    2,800 days
    2024-08-30: 5.2M2024-09-13: 4.3M2024-09-30: 5.1M2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M
    the 29 Aug 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Oct 2025

    Perrigo had 8.7M shares sold short in the 30 Sep 2025 report, 1.7× the same report last year.

    This period
    8.7M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    417K
    How far from its usual level
    +5.9
    Same report last year
    5.1M
    History used
    2,832 days
    2024-09-30: 5.1M2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M
    the 30 Sep 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    Perrigo had 11.5M shares sold short in the 15 Oct 2025 report, 2.1× the same report last year.

    This period
    11.5M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    449K
    How far from its usual level
    +9.6
    Same report last year
    5.5M
    History used
    2,847 days
    2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M
    the 15 Oct 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Nov 2025

    Perrigo had 10.1M shares sold short in the 31 Oct 2025 report, 2.0× the same report last year.

    This period
    10.1M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    521K
    How far from its usual level
    +6.5
    Same report last year
    5.0M
    History used
    2,863 days
    2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M
    the 31 Oct 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Nov 2025

    Perrigo had 11.9M shares sold short in the 14 Nov 2025 report, 2.4× the same report last year.

    This period
    11.9M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    626K
    How far from its usual level
    +7.1
    Same report last year
    5.0M
    History used
    2,877 days
    2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M
    the 14 Nov 2025 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Dec 2025

    Perrigo had 14.2M shares sold short in the 28 Nov 2025 report, 3.5× the same report last year.

    This period
    14.2M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    727K
    How far from its usual level
    +8.3
    Same report last year
    4.0M
    History used
    2,891 days
    2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M
    the 28 Nov 2025 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Dec 2025

    Perrigo had 13.9M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

    This period
    13.9M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    802K
    How far from its usual level
    +7.2
    Same report last year
    4.7M
    History used
    2,908 days
    2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M
    the 15 Dec 2025 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Jan 2026

    Perrigo had 15.4M shares sold short in the 31 Dec 2025 report, 3.4× the same report last year.

    This period
    15.4M (the 31 Dec 2025 report)
    Normal report (median of 24 earlier)
    5.4M
    Typical spread (median absolute deviation)
    920K
    How far from its usual level
    +7.3
    Same report last year
    4.5M
    History used
    2,924 days
    2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M
    the 31 Dec 2025 report24 earlier reportsnormal: 5.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 28 Jan 2026

    Perrigo had 13.9M shares sold short in the 15 Jan 2026 report, 2.5× the same report last year.

    This period
    13.9M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    5.6M
    Typical spread (median absolute deviation)
    988K
    How far from its usual level
    +5.7
    Same report last year
    5.5M
    History used
    2,939 days
    2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M2026-01-15: 13.9M
    the 15 Jan 2026 report24 earlier reportsnormal: 5.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 17 Feb 2026

    Perrigo saw 65 13F filers open a new position in the quarter ended 31 Dec 2025, 1.6× the same quarter last year.

    This period
    65 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    38.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.0
    Same quarter last year
    40
    History used
    4,475 days
    2023-12-31: 482024-03-31: 382024-06-30: 462024-09-30: 352024-12-31: 402025-03-31: 362025-06-30: 312025-09-30: 392025-12-31: 65
    the quarter ended 31 Dec 20258 earlier quartersnormal: 38.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 11 Feb 2026

    Perrigo had 15.8M shares sold short in the 30 Jan 2026 report, 3.0× the same report last year.

    This period
    15.8M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    6.0M
    Typical spread (median absolute deviation)
    1.4M
    How far from its usual level
    +4.8
    Same report last year
    5.3M
    History used
    2,954 days
    2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M2025-09-15: 7.1M2025-09-30: 8.7M2025-10-15: 11.5M2025-10-31: 10.1M2025-11-14: 11.9M2025-11-28: 14.2M2025-12-15: 13.9M2025-12-31: 15.4M2026-01-15: 13.9M2026-01-30: 15.8M
    the 30 Jan 2026 report24 earlier reportsnormal: 6.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  21. 11 Sep 2025Short interest and volume change

    had 7.4M shares sold short in the 29 Aug 2025 report, 1.4× the same report last year.

    Same report last year: 5.2M; its normal report is 5.0M.

    See the evidence
    This period
    7.4M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    377K
    How far from its usual level
    +4.3
    Same report last year
    5.2M
    History used
    2,800 days
    2024-08-30: 5.2M2024-09-13: 4.3M2024-09-30: 5.1M2024-10-15: 5.5M2024-10-31: 5.0M2024-11-15: 5.0M2024-11-29: 4.0M2024-12-13: 4.7M2024-12-31: 4.5M2025-01-15: 5.5M2025-01-31: 5.3M2025-02-14: 5.4M2025-02-28: 4.6M2025-03-14: 3.8M2025-03-31: 4.0M2025-04-15: 4.9M2025-04-30: 5.2M2025-05-15: 4.6M2025-05-30: 5.2M2025-06-13: 5.0M2025-06-30: 5.0M2025-07-15: 6.3M2025-07-31: 5.7M2025-08-15: 6.4M2025-08-29: 7.4M
    the 29 Aug 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 11 Sep 2025Insiders record

    Lennox Abigail (EVP and CSO) bought 1,255 shares of PRGO ($28,125) (dated 10 Sep 2025)

  23. 10 Sep 2025Insiders record

    Atkinson Charles (EVP, General Counsel & Sec.) bought 1,000 shares of PRGO ($23,200) (dated 9 Sep 2025)

  24. 23 Aug 2025Insiders record

    Willis Robert (EVP & CHRO) bought 1,488 shares of PRGO ($35,861) (dated 22 Aug 2025)

  25. 21 Aug 2025Insiders record

    Parker Geoffrey M. (director) bought 4,375 shares of PRGO ($100,494) [amended] (dated 20 Aug 2025)

  26. 20 Aug 2025Insiders change

    had 3 insiders buy $268K of its shares on the open market within 30 days (3 filings).

    Who bought: Lockwood-Taylor Patrick, Parker Geoffrey M., Bezerra Eduardo Guarita.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $268K
    Window
    21 Jul 2025 to 20 Aug 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  27. 20 Aug 2025Insiders record

    Bezerra Eduardo Guarita (EVP & Chief Financial Officer) bought 3,000 shares of PRGO ($68,220) (dated 19 Aug 2025)

  28. 20 Aug 2025Insiders record

    Parker Geoffrey M. (director) bought 4,375 shares of PRGO ($100,494) (dated 19 Aug 2025)

  29. 9 Aug 2025Insiders record

    Lockwood-Taylor Patrick (CEO) bought 4,460 shares of PRGO ($99,774) (dated 8 Aug 2025)

  30. 18 Jul 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['AGR', 'BUD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4837092
  31. 17 Jul 2025Lobbying record

    PERRIGO COMPANY: new lobbying registration (SQUIRE PATTON BOGGS) (dated 16 Apr 2025)

  32. 1 Jul 2025Filings record

    Director or officer change

  33. 4 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 4 Jun 2025Filings record

    Director or officer change

  35. 15 May 2025Insiders record

    Parker Geoffrey M. (director) bought 3,500 shares of PRGO ($94,850) (dated 14 May 2025)

  36. 26 Feb 2025Filings record

    Director or officer change

  37. 3 Feb 2025Filings record

    Director or officer change

  38. 16 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 16 Jan 2025Filings record

    Director or officer change

  40. 30 Jul 2024Filings record

    Director or officer change

Showing the newest 40 of 153 entries; narrow the window or the kind of data to see older ones.

Not listed: 200 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001585364
Ticker
PRGO
Domain
perrigo.com
Employer name
l perrigo, Perrigo Company, Perrigo New York, Inc., perrigo research and development and 1 more (5 unverified)
Fein
38-2799573, 88-4038827 (2 unverified)
Hq location
L2|DUBLIN 2|D02 T (1 unverified)
Lobbying client
laboratoire hra pharma, perrigo, perrigo inc through fti government affairs
Name
Abtei Omega Pharma GmbH, Aco Hud Nordic AB, Adriatic BST D.o.o. Podruznica Zagreb, Adriatic BST Trgovina in Storitve D.o.o and 131 more
Uei
JVBULDEL2NK9, KYVPPWDGD1G4, MPM5ZLA65GN9
Wikidata
Q2916497
Wikipedia
Perrigo
  • DOL H-1B labor condition applications and PERM certifications30 data points13 Apr 2020 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)16 records, 220 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings12 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)217 records20 Jan 2016 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1015 data points25 Jun 2011 to 30 Oct 2026
  • SEC Form 4 insider transactions88 records, 304 data points8 Jan 2016 to 14 Nov 2025
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1 record, 36 data points16 Feb 2010 to 6 Feb 2018
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026